1. Linfoma de Hodgkin en recaida
BEAM vs DexaBEAM
Schmitz N, Pfistner B, Sextro M, et al: Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin disease: A randomised trial. Lancet 359:2065-2071, 2002.
Revisión relevante del ASCO 2004
Moskowitz CH: Controversies in the management of relapsed and primary refractory Hodgkin´s lymphoma. In American Society of Clinical Oncology Educational Book, 40th Annual Meeting, 2004, pp 360- 367.
martes, 25 de noviembre de 2008
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario